Skip to main content
Clinical Trials/IRCT20220510054814N1
IRCT20220510054814N1
Completed
未知

Effectiveness and durability of intervention pain neuroscience education and selected exercises based on weight management on pain, function and psychological factors in patients with knee osteoarthritis

Rheumatology Research Center (RRC), Dr. Shariati Hospital0 sites129 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Knee osteoarthritis.
Sponsor
Rheumatology Research Center (RRC), Dr. Shariati Hospital
Enrollment
129
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Rheumatology Research Center (RRC), Dr. Shariati Hospital

Eligibility Criteria

Inclusion Criteria

  • Age 40 years or older
  • A clinical diagnosis of knee osteoarthritis (defined as knee pain for \>3 months and minimum 3 times a week, early morning stiffness \<30 minutes, crepitus, bony tenderness, and no palpable warmth)
  • Radiographically established knee osteoarthritis (determined by Kellgren and Lawrence grade 1 to 3 on the 1\-4 scale)
  • Ability to read and write Persian and having access to and ability to use a smartphone or tablet for a period of follow up or the presence of a person next to the patient to help her/him
  • No participation in formal strength training or physical therapy for more than 30 minutes a week in the past 6\-month

Exclusion Criteria

  • Illiterate patients without caregivers (child, nurse, caregiver)
  • Severe osteoporosis
  • Clinical history of tumors or cancer
  • Patients in the post\-surgery period or submitted to previous physical therapy (over 30 min) in the past six months or to any health/pain education strategy
  • Active Inflammatory joint diseases (rheumatoid arthritis, gout, calcium pyrophosphate deposition disease)
  • Underwent any lower extremity joint replacement Procedure
  • Alzheimer diseases
  • Severe Patellofemoral osteoarthritis
  • Neurological diseases (parkinson's disease, stroke, multiple sclerosis, muscular dystrophy, motor neurone disease, huntington's disease)
  • Autoimmune disease, and mental illnesses

Outcomes

Primary Outcomes

Not specified

Similar Trials